Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
5541.5000
62.00
(
1.13
%)
NSE
Sep 19, 2025
15:31 PM
Volume:
383.7K
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
10 Feb 2024
5541.50
1.13%
Alkem Labs (SELL): Good quarter; cut to SELL on stretched valuations
Sell:
Alkem Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 4800
Recommendation
Target
BOB Capital Markets Ltd.
Revenue grew 9% YoY in Q3 backed by strong India and ROW growth that offset lower US business
Alkem Laboratories Ltd. is trading above all available SMAs
More from Alkem Laboratories Ltd.
Recommended
Five Interesting Stocks Today - September 19, 2025
The Baseline |
19 Sep 2025, 04:31PM
Market closes lower, JSW Energy arm to acquire Tidong Power
Trendlyne Marketwatch |
19 Sep 2025, 03:58PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021